Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Memphis Meats Produces World’s First Poultry from Animal Cells

XTALKS VITALS NEWS

Chicken

Silicon Valley-based food manufacturing company, Memphis Meats, has produced the world’s first “clean poultry” by growing chicken and duck cells outside the animals.

Share this!

March 17, 2017 | by Sarah Hand, M.Sc.

What if consumers could enjoy eating meat, without contributing to the negative environmental effects of conventional livestock farming practices? Now, Silicon Valley-based food manufacturing company, Memphis Meats, has produced the world’s first “clean poultry” by growing chicken and duck cells outside the animals.

Chicken is an incredibly popular source of protein in the US, representing a $90 billion dollar a year industry. American consumers eat approximately 90 pounds of chicken per year.

While duck may not be as common in the US, it is more prevalent in other areas around the world, including mainland China. Consumers in the country eat over 6 billion pounds of duck per year.

“It is thrilling to introduce the first chicken and duck that didn’t require raising animals,” said Dr. Uma Valeti, co-founder and CEO of Memphis Meats. “This is a historic moment for the clean meat movement.”

Using their own technological platform, their poultry was grown from cultured chicken and duck stem cells. According to Memphis Meats, their method will allow for the production of multiple different types of meat, with the ability to control taste, texture and nutritional content.



“Chicken and duck are at the center of the table in so many cultures around the world, but the way conventional poultry is raised creates huge problems for the environment, animal welfare, and human health,” continued Valeti. “It is also inefficient.”

As with most new technologies, the company’s operation is currently on the small side and the meat is expensive to grow. Still, Memphis Meats anticipates being able to scale-up the technology, while reducing costs, to meet their goal of launching their consumer meat products in 2021.

“We aim to produce meat in a better way, so that it is delicious, affordable and sustainable. We really believe this is a significant technological leap for humanity, and an incredible business opportunity—to transform a giant global industry while contributing to solving some of the most urgent sustainability issues of our time.”

In early 2016, Memphis Meats became the first to produce a meatball composed entirely of lab-grown beef. The global meat market is a $750 billion industry, which Memphis Meats hopes to tap into with its slaughter-free meats.


Keywords: Food, Meat, Cell Culture


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian Cancer

March 29, 2017 - The US Food and Drug Administration (FDA) has approved Zejula (niraparib) as a maintenance treatment for women with certain types of recurrent cancers, including epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Featured In: Pharmaceutical News


Nektar’s Opioid Analgesic Meets Endpoints in Phase III Clinical Trial

March 28, 2017 - Nektar Therapeutics has announced that their opioid analgesic has met both its primary and secondary endpoint in a recent Phase III efficacy study.

Featured In: Clinical Trials News


Small Molecule May Disrupt Biofilm Formation on Implantable Medical Devices

March 28, 2017 - Researchers at Trinity College Dublin in Ireland have identified a small molecule capable of preventing bacterial biofilms from growing on medical implants.

Featured In: Medical Device News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

Strategies for Deploying Innovative Solutions for Perimeter Security


Natural History vs. Registry Studies in Rare Disease


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Combination Product Regulatory Requirement Complexities and the Impact of the 21st Century Cures Act


Copyright © 2016-2017 Honeycomb Worldwide Inc.